Danish biotech company granted millions to develop custom-made cancer vaccine

Innovation Fund Denmark has granted a small Danish biotech company millions to develop a cancer vaccine targeting the unique cell changes in the individual patient. If the company succeeds, it will enter a billion-dollar market.

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Frontpage right now

Saniona starter studie med diabetestablet

Kombinationsbehandlingen tesomet fra det danske biotekselskab Saniona er blevet formuleret i én samlet tablet, hvilket skal gøre den mulige diabetesbehandling mere bekvem for patienterne, og man har nu startet et fase 1-studie med kandidaten i den nye formulering.

Latest Top picks in English

Related articles